The Annexure

News to 16 October 2026 ·

Desk›Chemicals› Kobo Biotech Ltd

Kobo Biotech Ltd

BSE 531541 · NSE KOBO · ISIN INE881A01015 · Group Z · Active

Commodities › Chemicals › Chemicals & Petrochemicals › Commodity Chemicals

₹5.72

+1.96%

BSE close, 28 August 2026

Market cap

₹13.63 cr

2.4 cr shares · Micro cap

Free float

₹7.50 cr

as published

P/E · P/B

-2.7× · -0.10×

EPS ₹-2.11 · BV ₹-57.20

FY23-24 rev / PAT

— / -4.93

₹ cr, as filed

Filings, window

1

0 selected · 0%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹1.99 52-WK HIGH ₹9.99 ₹5.72 47% of range
Against 52-week high-42.7%
Against 52-week low+187.4%
Day change+1.96%
Size bandMicro cap
Index membershipNone

Valuation as published by BSE

Earnings per share₹-2.11
Price / earnings-2.71×
Price / book-0.10×
Book value — derived, price ÷ P/B₹-57.20
Return on equity3.79%
Operating margin—
Net margin—

Consistency check

P/B ÷ P/E, which must equal ROE
3.69%
ROE as published
3.79%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-24 · Q — -1.33 -0.56 — —
Mar-24 · Q — -1.26 -0.53 — —
FY23-24 — -4.93 -2.07 — —

Quarter on quarter

Net profit, quarter on quarter
-5.6%

Disclosure profile 1 filings in the window

0 median 16.0 sector max 59 1 0th percentile of 300 Chemicals filers
Shaded is the middle half of the sector, 12 to 20 filings. Measured against the 300 Chemicals companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Procedural
Compliance Certificate1
Procedural sub-total1
Total1

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group Z, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 98 trading days

1 filings · 0 selected · busiest 2026-10-15

Filings

1 in the window · 11 earlier on record

  1. 15 October 2026 ·

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Certificate under Reg. 74(5)of SEBI (DP)30.09.2026

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

RSS feed for Kobo Biotech Ltd · the 50 most recent filings